ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,296Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 2035

$1.41M Total Retail Price of All Prescriptions

Rank: 18 out of 2035

886 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 886 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 886 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 24,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 1,415 1,175 1 1
OMEPRAZOLE 1,121 963 2 5
LISINOPRIL 1,120 916 3 3
METFORMIN HCL 955 808 4 9
ALENDRONATE SODIUM 927 838 5 27
METOPROLOL TARTRATE 764 640 6 8
RANITIDINE HCL 692 557 7 28
LEVOTHYROXINE SODIUM 678 593 8 4
LOSARTAN POTASSIUM 677 622 9 15
AMLODIPINE BESYLATE 628 542 10 6
HYDROCODONE-ACETAMINOPHEN 594 394 S3 11 2
FUROSEMIDE 564 489 12 7
FLUTICASONE PROPIONATE 536 474 13 29
ATENOLOL 514 424 14 10
CARVEDILOL 419 365 15 22
LOVASTATIN 380 318 16 33
TAMSULOSIN HCL 369 337 17 25
GLIMEPIRIDE 367 277 18 55
LIDODERM 355 337 19 72
ISOSORBIDE MONONITRATE ER 342 277 20 32
PROAIR HFA 332 201 21 31
SERTRALINE HCL 327 264 22 23
HYDROCHLOROTHIAZIDE 326 231 23 12
CRESTOR 313 281 24 41
FENOFIBRATE 309 240 25 82
ATORVASTATIN CALCIUM 309 291 25 13
CLOPIDOGREL 288 232 27 30
DIOVAN 258 246 28 76
GABAPENTIN 258 219 28 14
WARFARIN SODIUM 246 199 30 11
POTASSIUM CHLORIDE 240 201 31 18
POLYETHYLENE GLYCOL 3350 239 212 32 48
LOSARTAN-HYDROCHLOROTHIAZIDE 238 213 33 47
PLAVIX 201 162 34 49
METOPROLOL SUCCINATE 198 173 35 16
NEXIUM 196 173 36 51
CEPHALEXIN 190 155 37 91
HYDRALAZINE HCL 183 153 38 45
VENTOLIN HFA 180 100 39 80
ADVAIR DISKUS 174 138 40 38
PRAVASTATIN SODIUM 173 119 41 17
SINGULAIR 171 126 42 119
IBUPROFEN 167 111 43 43
DIGOXIN 166 143 44 67
JANUVIA 164 153 45 85
AZITHROMYCIN 162 134 46 39
DONEPEZIL HCL 159 146 47 24
TRICOR 150 128 48 120
SPIRIVA 140 103 49 44
ALCOHOL PREP PADS 139 117 50 262
ZETIA 137 110 51 84
CLOTRIMAZOLE-BETAMETHASONE 135 120 52 123
ALLOPURINOL 134 132 53 34
FLOVENT HFA 134 85 53 238
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 102 55 26
LANTUS 130 85 56 40
SINGLE USE SWAB 130 111 56 163
ZOLPIDEM TARTRATE 129 110 58 21
LEVOFLOXACIN 128 116 59 99
NYSTATIN 128 102 59 103
CIPROFLOXACIN HCL 116 98 61 63
MELOXICAM 110 101 62 56
CARBIDOPA-LEVODOPA 108 96 63 94
MONTELUKAST SODIUM 107 82 64 187
VERAPAMIL ER 107 85 64 115
FAMOTIDINE 103 80 66 71
INSULIN SYRINGE 101 65 67 97
NOVOLOG 97 89 68 95
LACTULOSE 97 85 68 96
DIOVAN HCT 95 87 70 126
METHYLPREDNISOLONE 91 72 71 125
GLIPIZIDE 91 83 71 54
ACETAMINOPHEN-CODEINE 86 60 S3 73 52
ALCOHOL SWABS 82 56 74 182
LIPITOR 81 80 75 134
NIFEDIPINE ER 81 69 75 98
HEPARIN SODIUM 80 69 77 227
DOXAZOSIN MESYLATE 77 70 78 111
TRAZODONE HCL 75 52 79 50
VOLTAREN 75 70 79 141
DILTIAZEM 24HR ER 75 48 79 143
SPIRONOLACTONE 72 64 82 65
ATROVENT HFA 72 34 82 292
CLONIDINE HCL 70 56 84 61
PROMETHAZINE HCL 67 49 R 85 106
OXYBUTYNIN CHLORIDE 67 65 85 102
METFORMIN HCL ER 66 57 87 78
EXELON 66 56 87 151
PANTOPRAZOLE SODIUM 65 61 89 42
LANTUS SOLOSTAR 65 46 89 66
COMBIVENT 63 26 91 154
QUETIAPINE FUMARATE 63 41 91 70
NITROSTAT 61 46 93 167
ENALAPRIL MALEATE 61 26 93 60
GLYBURIDE 61 61 R 93 74
TRIAMTERENE-HCTZ 59 59 96 35
QVAR 59 34 96 234
BETAMETHASONE VALERATE 58 54 98 191
FINASTERIDE 58 58 98 105
LEVETIRACETAM 57 21 100 87
CYMBALTA 56 29 101 59
TRAMADOL HCL 55 55 102 19
HUMALOG 54 30 103 139
ULTRA COMFORT 54 43 103 466
GLYBURIDE-METFORMIN HCL 53 51 R 105 139
GEMFIBROZIL 53 24 105 114
BYSTOLIC 53 47 105 108
NIASPAN 53 38 105 165
NAMENDA 53 53 105 37
CITALOPRAM HBR 51 39 110 20
METRONIDAZOLE 50 38 111 276
MIRTAZAPINE 50 38 111 46
LYRICA 50 38 111 89
AVODART 50 50 111 225
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.